Loading...
Request sample
Sign in to send a request. Suppliers are told your name, company, role and country.
- Scientific name
- -
- Active
- Palmitoylethanolamide (PEA)
- Assay
- Standardized to Palmitoylethanolamide content
- Physical form
- Powder
- Dosage
- 300 mg
- MOQ · lead time
- -
About this ingredient
Levagen® by Saanroo is a high-purity palmitoylethanolamide (PEA), an endogenous fatty acid amide derived from lipid sources such as egg yolk, peanuts, and soybeans. Manufactured in cGMP facilities and self-affirmed GRAS, Levagen® acts as an endocannabinoid receptor agonist supporting healthy inflammatory response, joint comfort, sleep quality, and post-exercise recovery. This stable, odorless, and tasteless compound is a clinically validated alternative to CBD, suitable for joint health, immune support, and sports recovery formulations.
Categories
Immunity healthCognitive healthJoint & bone healthInflammation support
Specification
4 parametersReproduced exactly as the manufacturer states them. A parameter the catalogue does not hold shows as a dash rather than a default.
Identity
| Parameter | Value |
|---|---|
| Active compound | Palmitoylethanolamide (PEA) |
| Physical form | Powder |
Standardization
| Marker | Guaranteed level | Applies to | Test method |
|---|---|---|---|
| Palmitoylethanolamide content | Standardized to Palmitoylethanolamide content | - | - |
Use and handling
| Parameter | Value |
|---|---|
| Dosage studied | 300 mg |
Applications
6 formatsFormats the supplier has run at commercial scale. No inclusion levels have been supplied for this listing yet.
BeveragesCapsulesFunctional BeveragesGummiesPowder BlendsTablets